Mural Health and ProofPilot: Patients, Payments and Partnership

A strategic alliance between Mural Health and ProofPilot has been launched in order to enhance clinical trial operations for pharmaceutical and biotechnology clients. To maximize protocol observance, reduce patient turnover, and boost enrollment numbers in international clinical trials, the firms will combine the Mural Link^TM technology from Mural Health and the digital protocol automation solution from ProofPilot.

Improved Payment Model to Enhance Participant Compliance

A carefully thought-out payment structure is essential for ensuring strict patient compliance in clinical research investigations. Sam Whitaker, the CEO and founder of Mural Health, has a solid reputation of transforming the way clinical research respondents are compensated. He argues that by actually improving the participant’s experience by offering a variety of payment alternatives, their Mural Connect Platform will generate practical benefit for a research conducted. The platform would do away with the need to hand out actual debit cards and streamline the payment distribution process for jobs that have been successfully accomplished. The concept is particularly applicable in a decentralized clinical trial (DCT) setting and performs well for physical investigations.

Automation and Optionality for Sponsors and Sites

By their collaboration with ProofPilot, Mural Health will give financial backers and clinical investigation locations a new automated, turnkey solution that will lighten their workload while giving patients more options. Chris Venezia, CEO of ProofPilot, thinks that tightly linking payments to a range of tasks and automating payments will boost patient compliance in completing tasks that go beyond specific assignments. With their collaboration, the two businesses will build a synergistic infrastructure for the automation of next-generation digital protocols that will provide their respective clients a wide range of integrated features.

Excitement for a Market-Leading Protocol Automation Platform

Whitaker is ecstatic that their businesses are collaborating to offer a market-leading protocol automation technology. The alliance would make it simpler for investigational sites and clinical trial patients conduct and engage in research by enhancing the effectiveness of duties, operations, and, as of now, patient transactions. Clinical trial management will be significantly enhanced by the union of the Mural Link^TM platform from Mural Health and the digital protocol automation platform from ProofPilot.

About Mural Health

The participant management platform of the future is called Mural Health. Mural Link, a platform developed by the company, facilitates clinical trial participation, enhancing research efficiency and the caliber of clinical data sets. Mural Link provides cutting-edge participant payment software that offers participants control over how they are paid, eliminates predatory fees associated with prepaid debit cards, adds features to help individuals arrive at site visits (without accruing a cash outlay), facilitates communication between participants and site staff, and gathers participant data to identify people who are most likely to drop-out. The Mural Link platform can be quickly implemented to boost enrollment rates, protocol compliance, participant engagement, and retention.

Learn more about Mural Health on www.muralhealth.com or general@muralhealth.com.

About ProofPilot

The first completely automated digital protocol platform in the industry was developed by ProofPilot to support clinical studies. By orchestrating stakeholder tasks and streamlining clinical operations, the ProofPilot platform enhances stakeholder engagements and data integrity. For sites and patients, high-performance outcomes are produced by getting rid of guessing and research protocol discrepancies. As one of the initial worldwide digital clinical trial solutions providers, ProofPilot was established in 2014 and offers virtual, hybrid, and in-person research products for patients and investigational institutional Co-Pilot packages. Via our automation platform, ProofPilot streamlines the difficult by eliminating the uncertainty out of research, boosts quality by eradicating protocol conduct errors, saves time and effort by doing away with manual activities, and lowers expenses for screening, monitoring, and communication.

To learn more about ProofPilot, visit  https://www.proofpilot.com/

Engr. Dex Marco Tiu Guibelondo, BS Pharm, RPh, BS CpE

Editor-in-Chief, PharmaFEATURES